Metformin enhances insulin sensitivity by suppressing hepatic gluconeogenesis and improving peripheral glucose uptake, reducing hyperinsulinemia and downstream ovarian androgen production ( The extent of weight loss observed with GLP-1 receptor agonists, especially in combination with metformin, is clinically relevant in the context of PCOS, a condition in which insulin resistance, central obesity, and metabolic dysfunction contribute to eventual infertility and long-term cardiometabolic risk ( Given the heterogeneity of PCOS phenotypes, a personalized, combination-based therapeutic approach may optimize outcomes beyond a uniform treatment model
doi:10.1007/s11033-010-0447-x, PMID: 21107728 Williams TA, Mars AE, Buyske SG, Stenroos ES, Wang R, Factura-Santiago MF, Lambert GH, Johnson WG (2007) Risk of autistic disorder in affected offspring of mothers with a glutathione S -transferase P1 haplotype
Its not a failure of willpower, its not a lifestyle choice, but it really is a disease, said Dr
The body adapts to weight loss by lowering resting metabolic rate, increasing appetite-stimulating hormones, and conserving energy
The products of this company are not intended to diagnose, treat, cure, or prevent any medical condition or disease
Retatrutide: Dosage adjustments & personalization Even in clinical trials, retatrutide dosing isnt treated like a fixed plan that everyone follows exactly the same way